Eosinophils as putative therapeutic targets in bullous pemphigoid.

about

BP180 Is Critical in the Autoimmunity of Bullous Pemphigoid.New insights into pemphigoid diseases.Targeting the Interleukin-5 Pathway for Treatment of Eosinophilic Conditions Other than Asthma.

P2860

Q47105853-8EB469C0-586F-4142-A07D-60CD4D2ADC60 Q49842338-0DB4AA2D-D87B-4870-BBB6-D9144C5998AA Q52571066-1DEA81A1-6850-4466-8BE6-8D87EC783771

P2860

Eosinophils as putative therapeutic targets in bullous pemphigoid.

Item

http://www.wikidata.org/entity/Q47916162

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Eosinophils as putative therapeutic targets in bullous pemphigoid.

@en

Eosinophils as putative therapeutic targets in bullous pemphigoid.

@nl

type

Item

label

Eosinophils as putative therapeutic targets in bullous pemphigoid.

@en

Eosinophils as putative therapeutic targets in bullous pemphigoid.

@nl

prefLabel

Eosinophils as putative therapeutic targets in bullous pemphigoid.

@en

Eosinophils as putative therapeutic targets in bullous pemphigoid.

@nl

P1476

Eosinophils as putative therapeutic targets in bullous pemphigoid.

@en

P2093

Dagmar Simon

http://www.w3.org/2001/XMLSchema#string

Luca Borradori

http://www.w3.org/2001/XMLSchema#string

P2860

Biochemical and functional similarities between human eosinophil-derived neurotoxin and eosinophil cationic protein: homology with ribonuclease

Human eosinophils express the high affinity IgE receptor, FcεRI, in bullous pemphigoid

Eosinophil extracellular DNA traps in skin diseases.

A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180.

Distinct eosinophil cytokine expression patterns in skin diseases - the possible existence of functionally different eosinophil subpopulations.

92-kD gelatinase is produced by eosinophils at the site of blister formation in bullous pemphigoid and cleaves the extracellular domain of recombinant 180-kD bullous pemphigoid autoantigen.

The role of complement in experimental bullous pemphigoid.

Mechanism of membrane damage mediated by human eosinophil cationic protein.

Novel targeted therapies for eosinophil-associated diseases and allergy

The eosinophil: the cell and its weapons, the cytokines, its locations.

P304

1187-1192

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/EXD.13416

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Hans-Uwe Simon

P577

2017-08-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28833620

http://www.w3.org/2001/XMLSchema#string

Eosinophils as putative therapeutic targets in bullous pemphigoid.

about

P2860

P2860

Eosinophils as putative therapeutic targets in bullous pemphigoid.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698